Molecular signatures of inherited and acquired sporadic late onset

Por um escritor misterioso

Descrição

Acquired sporadic late onset nemaline myopathy (SLONM) and inherited nemaline myopathy (iNM) both feature accumulation of nemaline rods in muscle fibers. Unlike iNM, SLONM is amenable to therapy. The distinction between these disorders is therefore crucial when the diagnosis remains ambiguous after initial investigations. We sought to identify biomarkers facilitating this distinction and to investigate the pathophysiology of nemaline rod formation in these different disorders. Twenty-two muscle samples from patients affected by SLONM or iNM underwent quantitative histological analysis, laser capture microdissection for proteomic analysis of nemaline rod areas and rod-free areas, and transcriptomic analysis. In all iNM samples, nemaline rods were found in subsarcolemmal or central aggregates, whereas they were diffusely distributed within muscle fibers in most SLONM samples. In SLONM, muscle fibers harboring nemaline rods were smaller than those without rods. Necrotic fibers, increased endomysial connective tissue, and atrophic fibers filled with nemaline rods were more common in SLONM. Proteomic analysis detected differentially expressed proteins between nemaline rod areas and rod-free areas, as well as between SLONM and iNM. These differentially expressed proteins implicated immune, structural, metabolic, and cellular processes in disease pathophysiology. Notably, immunoglobulin overexpression with accumulation in nemaline rod areas was detected in SLONM. Transcriptomic analysis corroborated proteomic findings and further revealed substantial gene expression differences between SLONM and iNM. Overall, we identified unique pathological and molecular signatures associated with SLONM and iNM, suggesting distinct underlying pathophysiological mechanisms. These findings represent a step towards enhanced diagnostic tools and towards development of treatments for SLONM.
Molecular signatures of inherited and acquired sporadic late onset
T-cell dysregulation and inflammatory process in Gcn2 (Eif2ak4
Molecular signatures of inherited and acquired sporadic late onset
Disruption of Fgf13 Causes Synaptic Excitatory–Inhibitory
Molecular signatures of inherited and acquired sporadic late onset
Figure 8 from Regional distribution of synaptic markers and APP
Molecular signatures of inherited and acquired sporadic late onset
iPSC modeling of young-onset Parkinson's disease reveals a
Molecular signatures of inherited and acquired sporadic late onset
The diverse molecular profiles of lynch syndrome-associated
Molecular signatures of inherited and acquired sporadic late onset
Full article: Unlocking the Hidden Depths: Multi-Modal Integration
Molecular signatures of inherited and acquired sporadic late onset
Alzheimer's disease associated with Down syndrome: a genetic form
Molecular signatures of inherited and acquired sporadic late onset
Complex II - Bioblast
Molecular signatures of inherited and acquired sporadic late onset
Transcriptomic analysis of inherited and sporadic late-onset
Molecular signatures of inherited and acquired sporadic late onset
Genomic Fingerprint Associated with Familial Idiopathic Pulmonary
Molecular signatures of inherited and acquired sporadic late onset
Clonal hematopoiesis of indeterminate potential (CHIP): Linking
Molecular signatures of inherited and acquired sporadic late onset
Genetics of Alzheimer's Disease
Molecular signatures of inherited and acquired sporadic late onset
Epigenetic signatures of methylated DNA cytosine in Alzheimer's
Molecular signatures of inherited and acquired sporadic late onset
Loop Stefan Nicolau
Molecular signatures of inherited and acquired sporadic late onset
Proteomics of brain, CSF, and plasma identifies molecular
de por adulto (o preço varia de acordo com o tamanho do grupo)